We are live on ! Find out more
IDNA icon

iShares Genomics Immunology and Healthcare ETF
IDNA

60 hedge funds and large institutions have $61.8M invested in iShares Genomics Immunology and Healthcare ETF in 2026 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 6

46% more repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 13

12% more capital invested

Capital invested by funds: $55M → $61.8M (+$6.8M)

3% more funds holding

Funds holding: 58 → 60 (+2)

0.81% less ownership

Funds ownership: 41.71% → 40.91% (-0.81%)

Holders
60
Holders Change
+2
Holders Change %
+3.45%
% of All Funds
0.74%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
19
Reduced
13
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Bank of America
Bank of America
North Carolina
+$3.25M
2
Morgan Stanley
Morgan Stanley
New York
+$920K
3
SPIA
Steward Partners Investment Advisory
New York
+$685K
4
GS
GTS Securities
New York
+$676K
5
Ameriprise
Ameriprise
Minnesota
+$408K

Top Sellers

Rank Fund Capital Flow
1
Raymond James Financial
Raymond James Financial
Florida
-$1.85M
2
Jane Street
Jane Street
New York
-$1.37M
3
FTUS
Flow Traders U.S.
New York
-$1.08M
4
OC
Opal Capital
Florida
-$604K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$331K
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
51
Fidelity Investments
Massachusetts
$5.23K +$5.22K +180 New
GWM
52
Geneos Wealth Management
Colorado
$4.8K – – –
HWA
53
HHM Wealth Advisors
Tennessee
$3.92K – – –
1NWS
54
1 North Wealth Services
Maryland
$2.47K – – –
GSWM
55
Golden State Wealth Management
California
$2.28K – – –
RF
56
Rossby Financial
Florida
$1.75K +$116 +4 +7%
BBPWM
57
Blue Bell Private Wealth Management
Pennsylvania
$1.6K – – –
AF
58
Allworth Financial
California
$1.16K – – –
LFG
59
Larson Financial Group
Missouri
$416 +$406 +14 New
AC
60
AlphaCore Capital
California
$23 – – –
Jane Street
61
Jane Street
New York
– -$1.37M -52,452 Closed
FTUS
62
Flow Traders U.S.
New York
– -$1.08M -41,395 Closed
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
– -$331K -12,655 Closed
Citadel Advisors
64
Citadel Advisors
Florida
– -$301K -11,490 Closed
OC
65
Opal Capital
Florida
– -$604K -6,550 Closed
KAS
66
Kestra Advisory Services
Texas
– -$77.6K -2,963 Closed
1 2
3

IDNA Hedge Fund Activity: Q1 2026 in Review

60 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q1 2026, worth a combined $61.8M — up 12% from $55M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new IDNA positions and 6 closed out — a net gain of 3 holders — while 19 added to existing stakes and 13 trimmed.

The largest buyer was Bank of America, adding an estimated $3.25M. The largest seller was Raymond James Financial, cutting an estimated $1.85M.

  • 60 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q1 2026, up from 58 in Q4 2025.
  • Funds reported $61.8M of iShares Genomics Immunology and Healthcare ETF stock for Q1 2026, up 12% quarter-over-quarter.
  • 9 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q1 2026 and 6 closed out, a net change of +3 holders.
  • The largest iShares Genomics Immunology and Healthcare ETF buyer in Q1 2026 was Bank of America, an estimated $3.25M added.
  • The largest iShares Genomics Immunology and Healthcare ETF seller in Q1 2026 was Raymond James Financial, an estimated $1.85M sold.

Based on aggregated 13F filings for Q1 2026.